[Prevention by use of drugs of hyperbilirubinemia in the newborn. VI. Animal experiments and clinical tests of Vasalgin].
D000433:1-Propanol / Q000627:therapeutic use; D000498:Allyl Compounds / Q000627:therapeutic use; D000818:Animals; D000831:Animals, Newborn; D001463:Barbiturates / Q000627:therapeutic use*; D001663:Bilirubin / Q000097:blood; D004357:Drug Synergism; D006801:Humans; D006932:Hyperbilirubinemia / Q000517:prevention & control*; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000517:prevention & control*; D009963:Orotic Acid / Q000627:therapeutic use
D000498:Allyl Compounds; D001463:Barbiturates; D009963:Orotic Acid; D000433:1-Propanol; D001663:Bilirubin
Zur medikamentösen Prophylaxe der Neugeborenen-Hyperbilirubinämie. VI. Tierexperimentelle und klinische Erprobung von Vasalgin.